Outset Medical Statistics
Total Valuation
Outset Medical has a market cap or net worth of $117.17 million. The enterprise value is $46.71 million.
| Market Cap | 117.17M |
| Enterprise Value | 46.71M |
Important Dates
The next estimated earnings date is Wednesday, May 1, 2024, after market close.
| Earnings Date | May 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Outset Medical has 50.51 million shares outstanding. The number of shares has increased by 2.96% in one year.
| Shares Outstanding | 50.51M |
| Shares Change (YoY) | +2.96% |
| Shares Change (QoQ) | +0.70% |
| Owned by Insiders (%) | 3.97% |
| Owned by Institutions (%) | 104.49% |
| Float | 49.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.90 |
| Forward PS | 0.77 |
| PB Ratio | 0.95 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.26, with a Debt / Equity ratio of 1.11.
| Current Ratio | 5.26 |
| Quick Ratio | 4.33 |
| Debt / Equity | 1.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.59 |
Financial Efficiency
Return on equity (ROE) is -102.50% and return on invested capital (ROIC) is -65.53%.
| Return on Equity (ROE) | -102.50% |
| Return on Assets (ROA) | -52.40% |
| Return on Capital (ROIC) | -65.53% |
| Revenue Per Employee | $271,617 |
| Profits Per Employee | -$359,994 |
| Employee Count | 480 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 2.01 |
Taxes
In the past 12 months, Outset Medical has paid $523,000 in taxes.
| Income Tax | 523,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.05% in the last 52 weeks. The beta is 1.98, so Outset Medical's price volatility has been higher than the market average.
| Beta (1Y) | 1.98 |
| 52-Week Price Change | -87.05% |
| 50-Day Moving Average | 2.66 |
| 200-Day Moving Average | 7.65 |
| Relative Strength Index (RSI) | 49.74 |
| Average Volume (30 Days) | 971,727 |
Short Selling Information
The latest short interest is 8.36 million, so 16.55% of the outstanding shares have been sold short.
| Short Interest | 8.36M |
| Short Previous Month | 8.52M |
| Short % of Shares Out | 16.55% |
| Short % of Float | 16.84% |
| Short Ratio (days to cover) | 7.11 |
Income Statement
In the last 12 months, Outset Medical had revenue of $130.38 million and -$172.80 million in losses. Loss per share was -$3.48.
| Revenue | 130.38M |
| Gross Profit | 29.00M |
| Operating Income | -169.77M |
| Pretax Income | -172.27M |
| Net Income | -172.80M |
| EBITDA | -152.52M |
| EBIT | -159.60M |
| Loss Per Share | -$3.48 |
Balance Sheet
The company has $206.65 million in cash and $136.19 million in debt, giving a net cash position of $70.47 million or $1.40 per share.
| Cash & Cash Equivalents | 206.65M |
| Total Debt | 136.19M |
| Net Cash | 70.47M |
| Net Cash Per Share | $1.40 |
| Equity / Book Value | 122.89M |
| Book Value Per Share | 2.43 |
| Working Capital | 235.90M |
Cash Flow
In the last 12 months, operating cash flow was -$131.37 million and capital expenditures -$3.44 million, giving a free cash flow of -$134.81 million.
| Operating Cash Flow | -131.37M |
| Capital Expenditures | -3.44M |
| Free Cash Flow | -134.81M |
| FCF Per Share | -$2.72 |
Margins
Gross margin is 22.24%, with operating and profit margins of -130.22% and -132.54%.
| Gross Margin | 22.24% |
| Operating Margin | -130.22% |
| Pretax Margin | -132.14% |
| Profit Margin | -132.54% |
| EBITDA Margin | -116.98% |
| EBIT Margin | -122.41% |
| FCF Margin | -103.40% |
Dividends & Yields
Outset Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.96% |
| Shareholder Yield | -2.96% |
| Earnings Yield | -147.47% |
| FCF Yield | -115.05% |
Analyst Forecast
The average price target for Outset Medical is $5.30, which is 128.45% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.30 |
| Price Target Difference | 128.45% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 18.16% |
| EPS Growth Forecast (5Y) | -32.31% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Outset Medical has an Altman Z-Score of -4.28 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.28 |
| Piotroski F-Score | 3 |